Clinical Study on the Deep Remission of Rheumatoid Arthritis With Kidney Deficiency and Excessive Cold Syndrome by Bushen Quhan Zhiwang Decoction - Trial NCT06309030
Access comprehensive clinical trial information for NCT06309030 through Pure Global AI's free database. This phase not specified trial is sponsored by Liu Longxiao and is currently Not yet recruiting. The study focuses on Rheumatoid Arthritis. Target enrollment is 72 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Liu Longxiao
China-Japan Friendship Hospital
Timeline & Enrollment
N/A
Apr 01, 2024
Aug 01, 2026
Primary Outcome
disease activity score derivative for 28 joints (DAS28)
Summary
The investigators conduct this randomized controlled clinical trial to evaluate the efficacy
 and safety of the Bushen Quhan Zhiwang decoction in patients with RA with kidney deficiency
 and excessive cold syndrome who have not achieved deep remission and remained at a low level
 of disease activity despite the use of conventional synthetic disease-modifying antirheumatic
 drugs.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06309030
Non-Device Trial